Track the Epiminder Limited share price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are quoted on AU AU, under the supervision of ASX. Operating in the Healthcare & Pharma sector, Epiminder Limited has recorded 3 reports. Market capitalisation: €76k. The latest transaction was filed on 5 June 2026 (Purchase). Among the most active insiders: Philip Binns. Every trade is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
Epiminder Limited is a company in the health and pharmaceutical sector, focused on developing innovative solutions for chronic disease monitoring. It is listed on the XASX market.